Skip to main content
. 2023 Aug 21;76(6):627–639. doi: 10.4097/kja.23323

Fig. 2.

Fig. 2.

Effect of sevoflurane on the mRNA expression of NKG2D ligands. Results were analyzed using Kruskal-Wallis tests with post-hoc Conover comparisons. Variables are presented as the median with the first and third quartiles (n = 6 per group). C: control group, S6: sevoflurane 600 µM group, S12: sevoflurane 1200 µM group, ULBP: UL16-binding proteins, MICA/B: major histocompatibility complex class I chain-related molecules A/B, RPL19: ribosomal protein L19. *P < 0.05 compared to C.